The Novartis Biome, whose first digital health innovation lab is based in San Francisco, has been co-founded by its head Mohanad Fors, head of open innovation Shwen Gwee and head of innovation and ...

The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab, Endpoints News reports. The St. Louis facility was one of about 30 FDA ...

Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...

Novartis is paying Kyorin $55 million upfront for exclusive global rights to develop, manufacture and commercialize KRP-M223, a preclinical mast-cell-targeting candidate for chronic spontaneous ...

In lab studies, the orally active drug has been ... according to the biotech. Novartis has exclusive rights to MRT-6160 and follow-up VAV1 degraders and will be responsible for development ...

(Bloomberg) -- Novartis AG raised its forecast as sales of blockbuster medicines for heart disease and psoriasis outpaced expectations, giving the stock its biggest boost in nine months.

ZURICH, Feb 25 (Reuters) - Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 ...

Novartis' OAV101 IT showed a 2.39-point HFMSE improvement in SMA patients vs. 0.51 points in the sham control group. The STRENGTH study found OAV101 IT stabilized motor function in patients who ...